We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

GENFIT: The FDA Grants Fast Track Designation to GFT505 in NASH

News   Feb 18, 2014

 
GENFIT: The FDA Grants Fast Track Designation to GFT505 in NASH
 
 
 

RELATED ARTICLES

Researchers Patent Method for Making Anti-leukemia Compounds

News

Chemistry researchers at Oregon State University have patented a method for making anti-leukemia compounds that until now have only been available via an Asian tree that produces them.

READ MORE

New Class of Drugs Could Treat Ovarian Cancer

News

A team of researchers across The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.

READ MORE

FDA Approves First Treatment for Postpartum Depression

News

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE